Cargando…
Beyond the Knife in Renal Cell Carcinoma: A Systematic Review—To Ablate or Not to Ablate?
SIMPLE SUMMARY: Over the last 10 years, there has been a vast increase in the use of targeted and immunotherapy drugs in the management of advanced kidney cancer. As patients are living longer with cancer that has spread, the natural history has altered, with problems of poor tumour control in one o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340567/ https://www.ncbi.nlm.nih.gov/pubmed/37444565 http://dx.doi.org/10.3390/cancers15133455 |